World Congress on Allergy and Immunotherapy May 16-17, 2018 Osaka, Japan

ConferenceSeries is pleased to invite you to participate in the “World Congress on Allergy and Immunotherapy” to be held during May 16-17, 2018 in Osaka, Japan with a theme “Recent Advancements on Allergy and Immunotherapy”. ConferenceSeries organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Allergy Congress 2018 Conference provides unique networking opportunities for researchers and practitioners from all around the world to share the latest research and advancement in the field of hypersensitivity & immunotherapy. Allergy Congress is a global platform to discuss and learn about, exchange research evidence, innovative ideas and models of best practice. It covers a wide range of hypersensitivity and immunotherapy topics such as asthma, skin allergy, food allergy, drug allergy, cancer immunotherapy, cellular immunotherapy and many more. The Allergy Congress organizing committee is confident that participants will benefit from the scientific sessions. We welcome all the researchers/practitioners to join us at Osaka, Japan for two days of stimulating discussions, knowledge sharing, and networking events.

Why to Attend???

Allergy conferences provides a global platform for global networking and exchanging latest innovations in hypersensitivity and immunotherapy, offering opportunity to attend the presentations delivered by eminent experts from all over the world.

Participating in allergy Congress gives a way to meet, interact with, and make contacts with other experts in your specialty area. Most conferences will have authors, researchers who are recognized experts in the field.

Target Audience:

• Professors
• Doctors
• Pharmaceutical Industries
• Healthcare Industries
• Directors of Association and Societies
• Scientists
• Lecturers
• Allergists
• Immunologists
• Doctoral Students
• Young Research people

Track 1: Clinical Immunology & Allergy 

Clinical Immunology is a branch of Immunology which deals with clinical disorders at the molecular and cellular levels. Allergy involves an exaggerated response of the immune system, often to common substances such as foods or pollen. The immune system is a complex system that normally defends the body against foreign invaders, such as bacteria and viruses, while also surveying for conditions such as cancer and autoimmunity. Allergens are substances that are foreign to the body and that cause an allergic reaction.

 Immunology Conferences | Allergy Meetings | Hypersensitivity Events | Conference Series

Recommended conferences:

British Society for Allergy and Clinical Immunology Annual Meeting, 30th September-2nd October 2018, UK; 9^thMolecular Immunology & Immunogenetics Congress, March 08-09, 2018, London, UK; 9^th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA; 12th International Conference on Allergy, Asthma & Clinical Immunology, October 1-2, 2018; Moscow, Russia.

Track 2: Pediatric Allergy

Allergies are among the most common conditions affecting children. When the immune system of a child having an allergy, wrongly reacts to factors that are usually harmless; pet dander, pollen, dust, mold spores, insect stings, food, and medications are examples of such things. This reaction may cause their body to reciprocate with health problems such as asthma, hay fever, hives, eczema (a rash), or a very severe and unusual reaction called anaphylaxis.

Asthma Conferences | Allergy Meetings | Allergy Events | Conference Series

Recommended conferences:

COPD & Respiratory Allergy, February 2- 5, 2018, Dubai, United Arab Emirates; American Academy of Allergy, Asthma and Immunology Annual Meeting and World Allergy Organization Joint Meeting 2018 (AAAAI WAO 2018), March 2-5, 2018 Orlando, United States; Mainz Allergy Workshop 2018, March 22-23, 2018, Mainz, Germany; ICAAI 2018: 20th International Conference on Allergy, Asthma and Immunology, May 14 - 15, 2018, London, United Kingdom; European Academy of Allergy and Clinical Immunology conference, 26 - 30 MAY 2018, Munich, Germany; British Society for Allergy and Clinical Immunology Annual Meeting, 30th September-2nd October 2018, UK.

 

 

Track 3: Ocular Allergy

The eye, like the respiratory tract, can be a site of acute allergic reactions. Ocular allergy also called Allergic conjunctivitis occurs when something allergic to irritate the conjunctiva. This is the sensitive membrane covering the eye and the inside of the eyelid.

Allergic conjunctivitis begins when the immune system recognises an otherwise innocuous substance as an allergen. It leads your immune system to react more and produce antibodies called Immunoglobulin E (IgE). These antibodies drive to cells that release chemicals which cause an allergic reaction. In this case, allergic reactions include watering in eyes, itching, hurt or become red or swollen.

 Allergy Conferences | Asthma Meetings | Immunology Events | Conference Series

Recommended conferences:

British Society for Allergy and Clinical Immunology Annual Meeting, 30th September-2nd October 2018, UK; 9^thMolecular Immunology & Immunogenetics Congress, March 08-09, 2018, London, UK; 9^th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA; 12th International Conference on Allergy, Asthma & Clinical Immunology, October 1-2, 2018; Moscow, Russia.

Track 4: Infection and Allergy

Infection occurs when organism is attacked by disease causing agent, they multiply in the host body & produce toxins. Infection may remain localized or it can be spread through blood or lymphatic vessels to overall body. Infections are caused by infectious agents like virus, viroid, bacteria, prions etc. Host body fights infections by provoking immune system. Infections can be treated by medications like antibiotics, antivirals, antifungals etc.

Allergy Meetings | Immunotherapy Meetings | Immunology Meetings | Conference Series

Recommended conferences:

British Society for Allergy and Clinical Immunology Annual Meeting, 30th September-2nd October 2018, UK; 9^thMolecular Immunology & Immunogenetics Congress, March 08-09, 2018, London, UK; 9^th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA.

Track 5: Gastrointestinal immunology and allergy

Gastrointestinal tract is a lymphoid organ, and the lymphoid tissue within it is referred to as the gut-associated lymphoid tissue or GALT. Gastrointestinal allergy is an immediate hypersensitivity reaction of the digestive system after the ingestion of certain foods or drugs. GI allergy varies from food allergy, which can affect other organ systems. Distinctive symptoms constitute itching and swelling of the mouth and oral passages, nausea, vomiting, diarrhea, severe abdominal pain, and in severe cases, anaphylactic shock. Gastrointestinal food allergy also urges a challenge to the clinician because of its mutable symptomatology and lack of accurate diagnostic tests.

 Immunology Conferences | Asthma Summit | Allergy Events | Conference Series

Recommended conferences:

British Society for Allergy and Clinical Immunology Annual Meeting, 30th September-2nd October 2018, UK; 9^thMolecular Immunology & Immunogenetics Congress, March 08-09, 2018, London, UK; 9^th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA; 12th International Conference on Allergy, Asthma & Clinical Immunology, October 1-2, 2018; Moscow, Russia.

Track 6: Allergy Diagnosis & Medicine

Allergic diseases are the outcome of allergic inflammation that occurs as a result of an interaction between the environment and the patient's immune system resulting in the release of histamine and other pro-inflammatory mediators. Knowing exactly what body is allergic to can help lessen or prevent exposure and treat the reactions. Laboratory investigations are a useful tool in the diagnosis and management of allergic diseases and can provide aids to diagnose and assess disease activity.

 Allergy Congress | Asthma World Summit | Immunology Congress | Conference Series

Recommended conferences:

5^th International Workshop on Asthma and COPD 2018, January 18-20, 2018, Berlin, Germany; 12^th World Congress on Asthma, COPD & Respiratory Allergy, February 2- 5, 2018, Dubai, United Arab Emirates; American Academy of Allergy, Asthma and Immunology Annual Meeting and World Allergy Organization Joint Meeting 2018 (AAAAI WAO 2018), March 2-5, 2018 Orlando, United States; Mainz Allergy Workshop 2018, March 22-23, 2018, Mainz, Germany; ICAAI 2018: 20th International Conference on Allergy, Asthma and Immunology, May 14 - 15, 2018, London, United Kingdom; European Academy of Allergy and Clinical Immunology conference, 26 - 30 MAY 2018, Munich, Germany.

Track 7: Allergy Prevention, Risk Factors & Treatment

Allergies can be prevented by identifying & avoiding the ones which cause allergy to the body. One of the biggest causes of allergy is house dust mites, pets, mould spores, food allergies, insect bites stings, when trying to identify what causes or deteriorate your allergic symptoms, track your activities and what you eat, when symptoms occur and what seems to help. Host factors responsible for risk of allergy are heredity, sex, race and age. Exposure to allergens has been identified as an influential environmental factor, whereas passive smoking and pollution may act as an adjuvant.

 Allergy Meeting | Asthma Conference | Immunotherapy Meetings | Conference Series

Recommended conferences:

5^th International Workshop on Asthma and COPD 2018, January 18-20, 2018, Berlin, Germany; 12^th World Congress on Asthma, COPD & Respiratory Allergy, February 2- 5, 2018, Dubai, United Arab Emirates; American Academy of Allergy, Asthma and Immunology Annual Meeting and World Allergy Organization Joint Meeting 2018 (AAAAI WAO 2018), March 2-5, 2018 Orlando, United States; Mainz Allergy Workshop 2018, March 22-23, 2018, Mainz, Germany; ICAAI 2018: 20th International Conference on Allergy, Asthma and Immunology, May 14 - 15, 2018, London, United Kingdom; European Academy of Allergy and Clinical Immunology conference, 26 - 30 MAY 2018, Munich, Germany; British Society for Allergy and Clinical Immunology Annual Meeting, 30th September-2nd October 2018, UK.

Track 8: Biomarkers for Allergy, Asthma & Clinical Immunology

A biological marker is a physical sign or laboratory measurement that can function as a sign of biological or pathophysiological processes or as a riposte to a therapeutic intervention. Determining IgE of IgG in serum has been proved to be too unresponsive and too non-specific to identify individuals with sensitization, with and without clinical symptoms. In order to develop new diagnostic tools, it is relevant to search for markers that are strongly conjoin with allergy or tolerance. So the biomarkers can be used as diagnostic tools.

Immunology Summit | Allergy Immunotherapy Congress | Immunology Conference | Conference Series

Recommended conferences:

5^th International Workshop on Asthma and COPD 2018, January 18-20, 2018, Berlin, Germany; 12^th World Congress on Asthma, COPD & Respiratory Allergy, February 2- 5, 2018, Dubai, United Arab Emirates; American Academy of Allergy, Asthma and Immunology Annual Meeting and World Allergy Organization Joint Meeting 2018 (AAAAI WAO 2018), March 2-5, 2018 Orlando, United States; Mainz Allergy Workshop 2018, March 22-23, 2018, Mainz, Germany

Track 9: Immunotherapy

Immunotherapy is the treatment of disease by inducing, enhancing, or suppressing an immune response. In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer. With thousands of patents filed annually on the subject, it is estimated that there are thousands of immunotherapy licensing opportunities across technology transfer offices that are in need of development and commercialization partners. Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.

Asthma Summit | Asthma Workshop | Immunology Workshop | Conference Series

Recommended conferences:

5^th International Workshop on Asthma and COPD 2018, January 18-20, 2018, Berlin, Germany; 12^th World Congress on Asthma, COPD & Respiratory Allergy, February 2- 5, 2018, Dubai, United Arab Emirates; American Academy of Allergy, Asthma and Immunology Annual Meeting and World Allergy Organization Joint Meeting 2018 (AAAAI WAO 2018), March 2-5, 2018 Orlando, United States; Mainz Allergy Workshop 2018, March 22-23, 2018, Mainz, Germany; ICAAI 2018: 20th International Conference on Allergy, Asthma and Immunology, May 14 - 15, 2018, London, United Kingdom; European Academy of Allergy and Clinical Immunology conference, 26 - 30 MAY 2018, Munich, Germany

Track 10: Asthma

Asthma is a chronic condition that effects lungs & causes inflammation and constricting of the bronchial tubes, the pathways that allow air to enter and leave the lungs. If people with asthma are unveiled to a substance to which they are sensitive or a situation that changes their regular breathing patterns, the symptoms can become more severe. There are two types of asthma: allergic (caused by exposure to an allergen) and non-allergic (caused by stress, exercise, illnesses like a cold or the flu, or exposure to extreme weather, irritants in the air or some medications).

 Allergy Conferences | Allergy Meetings | Asthma Events | Conference Series

Recommended conferences:

5^th International Workshop on Asthma and COPD 2018, January 18-20, 2018, Berlin, Germany; 12^th World Congress on Asthma, COPD & Respiratory Allergy, February 2- 5, 2018, Dubai, United Arab Emirates; American Academy of Allergy, Asthma and Immunology Annual Meeting and World Allergy Organization Joint Meeting 2018 (AAAAI WAO 2018), March 2-5, 2018 Orlando, United States; Mainz Allergy Workshop 2018, March 22-23, 2018, Mainz, Germany; ICAAI 2018: 20th International Conference on Allergy, Asthma and Immunology, May 14 - 15, 2018, London, United Kingdom.

Track 11: Drug Allergy

Drug allergies are a set of symptoms caused by an allergic reaction to a drug. A drug allergy encompasses an immune response in the body that develops an allergic reaction to a medicine. If you develop a rash, hives or difficulty breathing after taking certain medications, you may have a drug allergy. As with other allergic reactions, these symptoms of drug allergy can occur when your body’s immune system becomes sensitive to a substance in the medication, identifies it as a foreign invader and releases chemicals to defend against it.

 Immunology Conferences | Allergy Meetings | Asthma Events | Conference Series

 

Recommended conferences:

COPD & Respiratory Allergy, February 2- 5, 2018, Dubai, United Arab Emirates; American Academy of Allergy, Asthma and Immunology Annual Meeting and World Allergy Organization Joint Meeting 2018 (AAAAI WAO 2018), March 2-5, 2018 Orlando, United States; Mainz Allergy Workshop 2018, March 22-23, 2018, Mainz, Germany; ICAAI 2018: 20th International Conference on Allergy, Asthma and Immunology, May 14 - 15, 2018, London, United Kingdom; European Academy of Allergy and Clinical Immunology conference, 26 - 30 MAY 2018, Munich, Germany; British Society for Allergy and Clinical Immunology Annual Meeting, 30th September-2nd October 2018, UK.

Track 12: Skin Allergy

Irritated skin can be caused by a many factors. These include immune system disorders, medications and infections. When an allergen is responsible for initiating an immune system response, then it is an allergic skin condition. When skin is contacted by a substance, body’s immune system is triggered thinking the substance as a foreign agent, because of this skin becomes sensitive & develops allergy. Contact with substance such as detergents, soaps or cleaning supplies causes skin allergy.

Allergy Conferences | Asthma Meetings | Immunology Events | Conference Series

Recommended conferences:

British Society for Allergy and Clinical Immunology Annual Meeting, 30th September-2nd October 2018, UK; 9^th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA; 12th International Conference on Allergy, Asthma & Clinical Immunology, October 1-2, 2018; Moscow, Russia

Track 13: ENT Allergy 

Allergy affecting Ear, Nose, and Throat comprises ENT allergy. Seasonal as well as long lasting allergies can contribute to enduring sinusitis, bronchitis, as well as ear problems. Allergies are diagnosed through the patient's history, physical examination as well as allergy testing. Once the distinct allergens are identified prevention techniques as well as immunotherapy can be used in addition to antihistamines in order to obtain optimal results.   

 Allergy Conferences | Allergy Meetings | Asthma Events | Conference Series

Recommended conferences:

European Academy of Allergy and Clinical Immunology conference, 26 - 30 MAY 2018, Munich, Germany; British Society for Allergy and Clinical Immunology Annual Meeting, 30th September-2nd October 2018, UK; 9^th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018, London, UK; 9^th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA.

Track 14: Food Allergy

Food allergy is caused when the body falsely makes an antibody (IgE) to fight against a specific food. When the food is next (or sometimes is just in contact with the skin) it provokes an immune system response which results in the commute of histamine and other substances in the body. These cause various symptoms, depending on where in the body they are exposed. For example, in the gut they may result in abdominal pain, vomiting and diarrhoea; in the skin, itching and swelling (rash or nettle rash), in the upper airways, a runny nose or sneezing; in the lower airways, a wheeze or cough.

 Allergy Summit | Asthma Congress | Immunology Meetings | Conference Series

Recommended conferences:

5^th International Workshop on Asthma and COPD 2018, January 18-20, 2018, Berlin, Germany; 12^th World Congress on Asthma, COPD & Respiratory Allergy, February 2- 5, 2018, Dubai, United Arab Emirates; American Academy of Allergy, Asthma and Immunology Annual Meeting and World Allergy Organization Joint Meeting 2018 (AAAAI WAO 2018), March 2-5, 2018 Orlando, United States; Mainz Allergy Workshop 2018, March 22-23, 2018, Mainz, Germany; European Academy of Allergy and Clinical Immunology conference, 26 - 30 MAY 2018, Munich, Germany.

Allergy & Asthma Market Analysis:

The allergy treatment market is the highly growing market in developed and developing countries due to the fast growing life science industry, rising focus on new treatment development for allergy specific drugs, and increasing prevalence of allergic diseases.

The allergy diagnostics market is expected to reach USD 5.74 Billion by 2022 from USD 3.49 Billion in 2017, at a CAGR of 10.5% from 2017 to 2022. The high incidence of allergic diseases is one of the major factors driving the growth of this market. The rising environmental pollution levels and the growing need for relatively faster, accurate, and high-throughput technologies for allergy diagnostics are the major factors supporting the growth of this market.

On the basis of allergens, the allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2017, the inhaled allergens segment is expected to account for the largest share of the allergy diagnostics market. Increasing environmental pollution is one of the major factors driving the growth of this segment.

Allergy Diagnostics Market, by Product & Service

• Assay Kits
• Instruments
  • Immunoassay Analyzers
  • Luminometers
  • ELISA Analyzers
  • Other Instruments
• Services

Allergy Diagnostics Market, by Test Type

• In Vivo Tests
• In Vitro Tests

Allergy Diagnostics Market, by Allergen

• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

Allergy Diagnostics Market, by End User

• Diagnostics Laboratories
• Hospital-based Laboratories
• Academic and Research Institutes
• Other End Users

Allergy Diagnostics Market, by Region

• North America
  • US
  • Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe (RoE)
• China
• Japan
• India
• Rest of Asia (RoA)
• Latin America
• Pacific & Oceania
• Middle East & Africa
• Asia
• Rest of the World (RoW)

Allergy Treatment Market: Region- wise overview

Depending on geographic regions, global allergy treatment market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan and Middle East & Africa. North America followed by Europe dominates the global allergy treatment market due to increasing number of patients with various type of allergies including respiratory allergy, skin allergy, eye allergy, etc. growing environmental pollution, developed healthcare infrastructure and growing demand for immunotherapy for treatment of allergies in these region. Asia-Pacific is the fastest emerging market for global allergy treatment due to growing allergic patient population, increasing awareness about advanced immunotherapy for treatment of allergies available in the market, developing healthcare infrastructure and rising government spending in healthcare industry in this region.

Key Players

Some of the key market players in global allergy treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and Vicks. Currently, the companies which operate in allergy treatment are entering into mergers and acquisition with other companies to expand its allergy treatment business. For instance, in June 2015, Allergy Therapeutics acquired Alerpharma S.A, a Spanish company develops and now offers allergy immunotherapy products and services to expand its allergy immunotherapy business. In addition, In November 2015, Pfizer Inc., a multinational pharmaceutical corporation entered into a merger with Allergan PLC, a pharmaceutical company to capture more market shares in the drug industry.

Asthma Market Analysis:

Global Asthma and COPD Drugs Market was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022, according to a new report published by Allied Market Research. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America accounted around for around half of the Global Asthma and COPD Drugs market share in 2015. According to the estimates published by the Global Initiative for Asthma (GINA), in the year 2013, around 300 million patients globally were reported to be afflicted with this disease and the number is expected to grow in the coming years. This is one of the crucial reasons for increasing adoption of asthma therapeutics worldwide. Furthermore, factors, such as the rising indoor and outdoor causative agents including pollution, allergens, and dust, among others, coupled with the changing lifestyles that influence the incidences of asthma are additionally fueling the demand for asthma therapeutics over the forecast period.

Key players

The key players in the Asthma and COPD Drugs market are highly focused on expanding their business operations in the fast-growing emerging countries with new product launches as the preferred strategy. The key players profiled in this report include GlaxoSmithKline (GSK) (U.K), Novartis AG (Switzerland), Merck & Co. (U.S), Abbott Laboratories (U.S), Boehringer Ingelheim (Germany), AstraZeneca (U.K), Roche Holding AG (Switzerland), Teva Pharmaceutical Industries(Israel), Vectura Group (U.K), and Pfizer Inc. (U.S).

Based on the importance, scope and market analysis Conference Series accommodates International symposiums and workshops exclusively on Allergy & Immunology research. Conference Series immunology & Allergy conferences are composed of Keynote lectures, plenary speeches, special scientific sessions, international symposiums, workshops, Exhibitions, and B2B Meetings.